U.S. Markets open in 7 hrs 44 mins

OvaScience, Inc. (OVAS)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.715-0.02 (-1.44%)
At close: 4:00PM EDT
People also watch
PTCTRGLSESPRTGTXOPHT

OvaScience, Inc.

9 Fourth Avenue
Waltham, MA 02451
United States
617-500-2802
http://www.ovascience.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees118

Key Executives

NameTitlePayExercisedAge
Dr. Michelle Dipp M.D., Ph.D.Co-Founder, Exec. Chairman, Acting Pres & Corp. Sec.830.41kN/A41
Dr. Jonathan L. Tilly Ph.D.Co-Founder and AdvisorN/AN/A54
Mr. Jonathan GillisPrincipal Financial Officer, Principal Accounting Officer & VP of Fin.N/AN/AN/A
Cara MayfieldDirector of Corp. CommunicationsN/AN/AN/A
Dr. Gabriel M. Cohn M.D.Head of Global Clinical & Medical Affairs and VPN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

OvaScience, Inc., a fertility company, discovers, develops, and commercializes fertility treatment options for women worldwide. The company’s patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman's own ovaries. It engages in developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize the fertility treatment consisting of AUGMENT to enhance the energy and health of the woman’s eggs by using mitochondria from a woman's EggPC cells; OvaTure to produce mature fertilizable eggs from a woman’s own EggPC cells without the need for hormone injections; OvaPrime treatment is used to replenish a woman's egg reserve by transferring the EggPCs from woman's own ovaries; and OvaXon for the prevention of inherited human disease and improvement of animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.

Corporate Governance

OvaScience, Inc.’s ISS Governance QualityScore as of June 2, 2017 is 9. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.